Damian Bartuzi

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

Wawruszak, Anna; Luszczki, Jarogniew; Bartuzi, Damian; Kalafut, Joanna et al.

Part of Journal of enzyme inhibition and medicinal chemistry (Print), 2025

• DOI for Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies
• Download full text (pdf) of Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations

Wrobel, Tomasz M.; Bartuzi, Damian; Kaczor, Agnieszka A.

Part of Journal of Chemical Information and Modeling, p. 7679-7686, 2024

• DOI for Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations
• Download full text (pdf) of Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations

Discovery and in vitro Evaluation of Novel Serotonin 5-HT_2A Receptor Ligands Identified Through Virtual Screening

Zieba, Agata; Bartuzi, Damian; Stepnicki, Piotr; Matosiuk, Dariusz et al.

Part of ChemMedChem, 2024

• DOI for Discovery and in vitro Evaluation of Novel Serotonin 5-HT_2A Receptor Ligands Identified Through Virtual Screening

Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis

Kaczor, Agnieszka A.; Wrobel, Tomasz M.; Bartuzi, Damian

Part of Molecules, 2023

• DOI for Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
• Download full text (pdf) of Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis

Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia

Stepnicki, Piotr; Wosko, Sylwia; Bartyzel, Agata; Zieba, Agata et al.

Part of Molecules, 2023

• DOI for Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia
• Download full text (pdf) of Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

Wawruszak, Anna; Luszczki, Jarogniew; Bartuzi, Damian; Kalafut, Joanna et al.

Part of Journal of enzyme inhibition and medicinal chemistry (Print), 2025

• DOI for Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies
• Download full text (pdf) of Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations

Wrobel, Tomasz M.; Bartuzi, Damian; Kaczor, Agnieszka A.

Part of Journal of Chemical Information and Modeling, p. 7679-7686, 2024

• DOI for Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations
• Download full text (pdf) of Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations

Discovery and in vitro Evaluation of Novel Serotonin 5-HT_2A Receptor Ligands Identified Through Virtual Screening

Zieba, Agata; Bartuzi, Damian; Stepnicki, Piotr; Matosiuk, Dariusz et al.

Part of ChemMedChem, 2024

• DOI for Discovery and in vitro Evaluation of Novel Serotonin 5-HT_2A Receptor Ligands Identified Through Virtual Screening

Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia

Stepnicki, Piotr; Wosko, Sylwia; Bartyzel, Agata; Zieba, Agata et al.

Part of Molecules, 2023

• DOI for Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia
• Download full text (pdf) of Development and Characterization of Novel Selective, Non-Basic Dopamine D-2 Receptor Antagonists for the Treatment of Schizophrenia

Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes

Bartuzi, Damian; Kedzierska, Ewa; Targowska-Duda, Katarzyna M.; Koszla, Oliwia et al.

Part of Scientific Reports, 2022

• DOI for Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes
• Download full text (pdf) of Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes

Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis

Kaczor, Agnieszka A.; Wrobel, Tomasz M.; Bartuzi, Damian

Part of Molecules, 2023

• DOI for Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
• Download full text (pdf) of Allosteric Modulators of Dopamine D-2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis